Corcept Therapeutics Incorporated (CORT)

NASDAQ: CORT · Real-Time Price · USD

122.25

+1.20 (0.99%)

At close: Aug 21, 2026, 4:00 PM EDT

120.00

-2.25 (-1.84%)

After-hours: Aug 21, 2026, 6:28 PM EDT

Corcept Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	111.04	120.5	127.67	135.55	66.33	77.62
Short-Term Investments	197.16	251.66	255.67	232.67	365.34	145.92
Cash & Short-Term Investments	308.2	372.15	383.33	368.22	431.67	223.54
Cash Growth	-9.94%	-2.92%	4.10%	-14.70%	93.11%	-49.28%
Accounts Receivable	76.92	59.79	53.98	41.12	31.06	27.63
Other Receivables	-	-	-	14	15.8	1.4
Receivables	76.92	59.79	53.98	55.12	46.86	29.03
Inventory	13.19	12.87	12.41	7.73	6.1	4.99
Prepaid Expenses	17.57	23.26	9.49	4.32	14.62	8.92
Other Current Assets	23.81	17.4	12.39	23.24	-	-
Total Current Assets	439.68	485.46	471.6	458.64	499.25	266.46
Property, Plant & Equipment	11.99	6.47	8.01	0.32	1.78	1.52
Long-Term Investments	236.45	160.27	219.83	57.18	4.95	112.28
Long-Term Deferred Tax Assets	178.68	168.2	130.91	90.61	61.47	27.46
Other Long-Term Assets	21.9	16.25	10.19	14.79	15.99	16.05
Total Assets	888.7	836.65	840.55	621.52	583.43	423.76

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Accounts Payable	14.91	40.44	15.38	17.4	11.98	6.91
Accrued Expenses	122.22	117.64	120.52	70.49	44.52	39.3
Current Portion of Leases	1.92	1.08	0.83	0.15	1.14	0.53
Current Income Taxes Payable	-	-	-	1.81	0.09	0.51
Other Current Liabilities	14.75	6.91	4.04	14.65	14.76	0.3
Total Current Liabilities	153.8	166.09	140.77	104.51	72.49	47.54
Long-Term Leases	7.5	5.02	6.11	-	-	-
Other Long-Term Liabilities	21.62	17.74	14.08	10.31	9.1	0.41
Total Liabilities	182.93	188.85	160.96	114.81	81.59	47.95

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Common Stock	0.14	0.14	0.14	0.13	0.13	0.13
Additional Paid-In Capital	1,049	968.6	832.11	738.52	662.34	591.35
Retained Earnings	654.61	643.39	543.74	402.53	296.39	194.97
Treasury Stock	-998.01	-966.59	-696.17	-635.08	-456.15	-410.41
Comprehensive Income & Other	0.44	2.26	-0.22	0.61	-0.87	-0.23
Shareholders' Equity	705.78	647.81	679.59	506.71	501.84	375.81
Total Liabilities & Equity	888.7	836.65	840.55	621.52	583.43	423.76

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Total Debt	9.42	6.11	6.94	0.15	1.14	0.53
Net Cash (Debt)	535.23	526.32	596.23	425.25	435.48	335.29
Net Cash Growth	5.28%	-11.73%	40.21%	-2.35%	29.88%	-29.32%
Net Cash Per Share	4.53	4.39	5.25	3.81	3.76	2.66
Filing Date Shares Outstanding	108.1	106.37	105.5	103.52	107.9	105.96
Total Common Shares Outstanding	107.92	105.97	105.11	103.41	107.84	105.94
Working Capital	285.87	319.38	330.83	354.13	426.76	218.92
Book Value Per Share	6.54	6.11	6.47	4.90	4.65	3.55
Tangible Book Value	705.78	647.81	679.59	506.71	501.84	375.81
Tangible Book Value Per Share	6.54	6.11	6.47	4.90	4.65	3.55
Machinery	-	-	-	-	-	1.16
Leasehold Improvements	-	-	-	-	-	1.26

SEC Filings: 10-K · 10-Q